Oral forms: If a dose of this medicine is missed, take/administer it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one. Parenteral forms: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Oral forms: Seek emergency medical treatment or contact the doctor in case of an overdose. Parenteral forms: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be instituted by the doctor if an overdose is suspected.
Phenylephrine (moderate)
Metoprolol (moderate)
Potassium Chloride (severe)
Acebutolol (moderate)
Haloperidol (moderate)
Promethazine (moderate)
Chlorpheniramine (moderate)
Ketoconazole (moderate)
Potassium Citrate (severe)
This medicine is used for controlling tremors that are caused due to relaxation of muscles in parkinson's disease.
This medicine is used as antidote for toxicity or poisoning of anticholinesterase class of medicines.
This medicine is used to relieve symptoms such as abdominal cramps, stomach pain, diarrhea, indigestion, etc. associated with irritable bowel syndrome.
This medicine is used for the treatment of peptic ulcer disease by reducing visceral spasm and gastric secretion.
This medicine is used for controlling urinary incontinence by contracting the bladder muscles in condition like neurogenic bladder (lack of bladder control due to nerve problem).
Dry skin
Constipation
Difficulty in swallowing
Blurred vision
Increased heartrate (rare)
Headache (rare)
Loss of taste
Nervousness
This medicine is not recommended for use in patients with a known allergy to Peptard Drop 125 mcg/mL 10 mL or any other inactive ingredients present in the formulation.
This medicine is not recommended for use in patients with obstructive uropathy due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with myasthenia gravis due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with paralytic ileus due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with closed-angle glaucoma due to the increased risk of worsening of the patient's condition.